[Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].

J. Tímár,M. Kásler,A. Heringh,Miklós Soós,D. Mathiász,A. Romány,A. Józsa,L. Szilák,T. Forrai,L. Patthy,G. Kovacs
DOI: https://doi.org/10.1556/MOnkol.53.2009.4.1
2009-12-01
Magyar Onkológia
Abstract:In the 3rd year of the program 8 new molecular diagnostic services have been introduced to clinic in the management of breast-, lung-, colorectal cancers as well as in GIST and melanoma. Two patents have been filed for innovative modulation of mito/motogenic signaling pathways in cancer cells. In preclinical models of human cancer a functional imaging technique was developed to detect vascular eff ects of erythropoietin. Using a genomic approach, the sequential changes in human melanoma during systemic dissemination were determined revealing several novel potential prognostic factors and some interesting novel targets for therapy.
What problem does this paper attempt to address?